Literature DB >> 21394599

Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET/CT.

Rajan Rakheja1, William Makis, Marc Hickeson.   

Abstract

A 69-year-old woman who presented with left lower quadrant abdominal pain and elevated serum cancer antigen 125 (CA-125) levels was referred for an MRI and an (18)F-FDG PET/CT to evaluate a suspicious abdominal mass seen on ultrasound. PET/CT showed extensive, intensely FDG-avid, omental and pelvic peritoneal thickening with no suspicious ovarian or colon masses. Based on the PET/CT results, the patient had extensive debulking surgery and histopathological evaluation revealed an extraovarian primary peritoneal carcinoma (EOPPC). (18)F-FDG PET/CT may be useful in differentiating EOPPC from other types of peritoneal carcinomatosis, and in determining the extent of the disease to better guide surgical management and improve long term outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21394599     DOI: 10.1007/s00261-011-9722-0

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  4 in total

Review 1.  Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

Authors:  Seung Yoon Yang; Jae Hyun Kang; Ho Seung Kim; Yoon Dae Han; Byung Soh Min; Kang Young Lee
Journal:  J Gastrointest Oncol       Date:  2019-12

2.  Primary peritoneal serous carcinoma, an extremely rare malignancy: A case report and review of the literature.

Authors:  Woo-Sung Yun; Jung-Min Bae
Journal:  Oncol Lett       Date:  2016-05-05       Impact factor: 2.967

3.  Extraovarian Primary Peritoneal Carcinomatosis: A Case Report.

Authors:  Gregory Nicolas; Tony Kfoury; Hassan Fawaz; Mahdi Issa
Journal:  Am J Case Rep       Date:  2017-06-26

4.  Correlation of preoperative magnetic resonance imaging of peritoneal carcinomatosis and clinical outcome after peritonectomy and HIPEC after 3 years of follow-up: preliminary results.

Authors:  B Klumpp; P Aschoff; N Schwenzer; I Koenigsrainer; S Beckert; C D Claussen; S Miller; A Koenigsrainer; C Pfannenberg
Journal:  Cancer Imaging       Date:  2013-12-30       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.